|
Microarray Analysis for Human Genetic Disease Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Microarray Analysis for Human Genetic Disease conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Microarray Analysis for Human Genetic Disease Clinical research trials and Microarray Analysis for Human Genetic Disease medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Microarray Analysis for Human Genetic Disease. Microarray Analysis for Human Genetic Disease Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Microarray Analysis for Human Genetic Disease clinical trial. Subjects typically recieve the finest healthcare available for their Microarray Analysis for Human Genetic Disease condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Microarray Analysis for Human Genetic Disease  Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
For Condition: Breast Neoplasm,Hereditary Neoplastic Syndrome,Melanoma,Ovarian Neoplasm
Status: Recruiting
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: This study will look at genetic influences in the development of male and female breast cancer and ovarian cancer that run in families. It will use a new technology called cDNA microarray hybridization that looks at a wide array of genes to identify disease-associated patterns in the human genome (complete set of human genes). Numerous studies have linked particular genes to a given disease, but there is very little information on patterns of gene expression (production of proteins from genetic coding) in the entire human genome. Pinpointing genetic abnormalities in disease may help identify individuals at increased risk and perhaps lead to new avenues of treatment or prevention. A primary goal of this study will be to create a database of gene expression for human cancers and other disorders that will provide the basis for finding genetic abnormalities in disease. Tumors specimens used in this study will be taken from tissues biopsied from patients with breast or ovarian cancer or melanoma as part of their routine care. Patients in the study will be among those receiving care at the: Department of Oncology, University Hospital, University of Lund, Sweden (breast cancer); Department of Medicine, University of Michigan, Ann Arbor, Michigan (breast cancer); Surgery Branch, National Cancer Institute, Bethesda, Maryland (melanoma). Patients in the study will have a family history taken and will complete a questionnaire. Some patients will be asked to have a blood test. Breast cancer patients will have a mammogram if one has not been done within the last year.
Details: The purpose of our study is to make use of a novel technology that the Cancer Genetics Branch of the NHGRI has been a leader in developing. This technology for genome-wide expression analysis, cDNA microarray hybridization, is the focus of our protocol. We will access tissue banks collected by our collaborators which contain excess tissues obtained during routine clinical care. Specimens will be processed for large scale gene expression analysis using cDNA microarrays. The development of this gene expression database is the primary purpose of this study. Currently available and new bioinformatics tools will be applied to the data for the characterization of disease subsets (e.g., early vs. advanced stage cancer) as well as to mine the data for specific genes which are linked to given disease states.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Clinical inclusion/exclusion criteria will be dependent upon the collaborating Institutions' requirements.
Total Enrollment: 1500
Location and Contact Information:
National Human Genome Research Institute (NHGRI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 990130; 99-HG-0130
Study Start Date: June 29, 1999
Record last reviewed: May 30, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001898
Other Melanoma Studies:
1. A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion with Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients with Locally Advanced Extremity Melanoma
2. Immunotherapy with Autologous Dexosomes for Patients with Stage IV Melanoma
3. Vaccine Plus Interleukin-2 Treatment of Metastatic Melanoma
4. Stem Cell Transplant for Malignant Melanoma
5. Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox and Vaccinia Viruses Encoding the Tyrosinase Antigen
Related Studies:
Other Melanoma Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Microarray Analysis for Human Genetic Disease
|
|
|
|
|
|
|
|
